List Name |
Annotation |
Enrichment |
p-value |
T-helper 1 type immune response |
AmiGO Browser |
53.94 |
6.28e-04 |
alpha-beta T cell differentiation during immune response |
AmiGO Browser |
47.59 |
8.11e-04 |
T cell activation during immune response |
AmiGO Browser |
47.59 |
8.11e-04 |
CD4-positive, alpha-beta T cell differentiation during immune response |
AmiGO Browser |
47.59 |
8.11e-04 |
leukocyte activation during immune response |
AmiGO Browser |
47.59 |
8.11e-04 |
lymphocyte activation during immune response |
AmiGO Browser |
47.59 |
8.11e-04 |
cell activation during immune response |
AmiGO Browser |
47.59 |
8.11e-04 |
T cell differentiation during immune response |
AmiGO Browser |
47.59 |
8.11e-04 |
T-helper cell differentiation |
AmiGO Browser |
47.59 |
8.11e-04 |
CD4-positive, alpha beta T cell differentiation |
AmiGO Browser |
42.58 |
1.02e-03 |
alpha-beta T cell differentiation |
AmiGO Browser |
28.90 |
2.21e-03 |
alpha-beta T cell activation |
AmiGO Browser |
22.47 |
3.64e-03 |
DNA integration |
AmiGO Browser |
101.14 |
9.85e-03 |
lymphocyte costimulation |
AmiGO Browser |
57.79 |
0.02 |
T cell costimulation |
AmiGO Browser |
57.79 |
0.02 |
central nervous system neuron development |
AmiGO Browser |
57.79 |
0.02 |
T cell differentiation |
AmiGO Browser |
9.99 |
0.02 |
sister chromatid cohesion |
AmiGO Browser |
44.95 |
0.02 |
regulation of cell volume |
AmiGO Browser |
44.95 |
0.02 |
central nervous system neuron differentiation |
AmiGO Browser |
40.45 |
0.02 |
endoderm development |
AmiGO Browser |
33.71 |
0.03 |
negative regulation of axon extension |
AmiGO Browser |
33.71 |
0.03 |
positive regulation of gene expression, epigenetic |
AmiGO Browser |
33.71 |
0.03 |
cell fate commitment |
AmiGO Browser |
7.29 |
0.03 |
galactose metabolic process |
AmiGO Browser |
31.12 |
0.03 |
regulation of T-helper cell differentiation |
AmiGO Browser |
31.12 |
0.03 |
apoptotic program |
AmiGO Browser |
6.92 |
0.03 |
adaptive immune response |
AmiGO Browser |
6.80 |
0.04 |
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
AmiGO Browser |
6.80 |
0.04 |
indole and derivative metabolic process |
AmiGO Browser |
26.97 |
0.04 |
negative regulation of axonogenesis |
AmiGO Browser |
26.97 |
0.04 |
indole derivative metabolic process |
AmiGO Browser |
26.97 |
0.04 |
indolalkylamine metabolic process |
AmiGO Browser |
26.97 |
0.04 |
oligosaccharide biosynthetic process |
AmiGO Browser |
26.97 |
0.04 |
DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis |
AmiGO Browser |
25.28 |
0.04 |
lymphocyte differentiation |
AmiGO Browser |
6.32 |
0.04 |
specification of organ identity |
AmiGO Browser |
23.80 |
0.04 |
cell-cell signaling during cell fate commitment |
AmiGO Browser |
23.80 |
0.04 |
induction of an organ |
AmiGO Browser |
23.80 |
0.04 |
induction |
AmiGO Browser |
23.80 |
0.04 |
positive regulation of interleukin-2 biosynthetic process |
AmiGO Browser |
23.80 |
0.04 |
negative regulation of neurogenesis |
AmiGO Browser |
20.23 |
0.05 |
Wnt receptor signaling pathway |
AmiGO Browser |
5.58 |
0.05 |
regulation of interleukin-2 biosynthetic process |
AmiGO Browser |
19.26 |
0.05 |
release of cytochrome c from mitochondria |
AmiGO Browser |
18.39 |
0.05 |
transmembrane receptor protein tyrosine phosphatase signaling pathway |
AmiGO Browser |
18.39 |
0.05 |
negative regulation of Wnt receptor signaling pathway |
AmiGO Browser |
16.86 |
0.06 |
regulation of axon extension |
AmiGO Browser |
16.18 |
0.06 |
apoptotic mitochondrial changes |
AmiGO Browser |
15.56 |
0.06 |
positive regulation of peptidyl-tyrosine phosphorylation |
AmiGO Browser |
15.56 |
0.06 |
estrogen receptor signaling pathway |
AmiGO Browser |
14.98 |
0.06 |
interleukin-2 biosynthetic process |
AmiGO Browser |
14.45 |
0.07 |
interleukin-2 production |
AmiGO Browser |
14.45 |
0.07 |
chromatin assembly or disassembly |
AmiGO Browser |
4.73 |
0.07 |
T cell activation |
AmiGO Browser |
4.68 |
0.07 |
cell differentiation |
AmiGO Browser |
1.71 |
0.07 |
cellular developmental process |
AmiGO Browser |
1.71 |
0.07 |
positive regulation of protein amino acid phosphorylation |
AmiGO Browser |
13.05 |
0.07 |
positive regulation of amine metabolic process |
AmiGO Browser |
13.05 |
0.07 |
positive regulation of amino acid metabolic process |
AmiGO Browser |
13.05 |
0.07 |
leukocyte differentiation |
AmiGO Browser |
4.42 |
0.08 |
oligosaccharide metabolic process |
AmiGO Browser |
12.26 |
0.08 |
positive regulation of phosphate metabolic process |
AmiGO Browser |
11.56 |
0.08 |
regulation of epithelial cell proliferation |
AmiGO Browser |
11.56 |
0.08 |
positive regulation of phosphorylation |
AmiGO Browser |
11.56 |
0.08 |
DNA damage response, signal transduction by p53 class mediator |
AmiGO Browser |
11.56 |
0.08 |
axon extension |
AmiGO Browser |
11.56 |
0.08 |
DNA damage response, signal transduction resulting in induction of apoptosis |
AmiGO Browser |
11.24 |
0.09 |
epithelial cell proliferation |
AmiGO Browser |
11.24 |
0.09 |
biogenic amine biosynthetic process |
AmiGO Browser |
11.24 |
0.09 |
meiotic recombination |
AmiGO Browser |
10.93 |
0.09 |
regulation of signal transduction |
AmiGO Browser |
2.37 |
0.09 |
regulation of axonogenesis |
AmiGO Browser |
10.37 |
0.09 |
metanephros development |
AmiGO Browser |
9.87 |
0.10 |
myeloid leukocyte activation |
AmiGO Browser |
9.41 |
0.10 |
intracellular signaling cascade |
AmiGO Browser |
1.71 |
0.10 |
regulation of Wnt receptor signaling pathway |
AmiGO Browser |
9.19 |
0.10 |